News & Opinion

Diabetes News

Diabetes Pill Shows Additional Weight-Loss Promise

October 30, 2017

An oral drug for type 2 diabetes worked just as well as the injectable version in controlling blood sugar and helping with weight loss.

Researchers from the University of Leicester Diabetes Research Centre in England discovered that oral semaglutide, which is taken once daily, resulted in better glycemic control Continue Reading →

Statin Use May Boost Diabetes Risk in Some People

October 25, 2017

People already susceptible to developing type 2 diabetes may increase that risk by taking the cholesterol-lowering med,

Young People on Antidepressants at Increased Risk of Developing Type 2 Diabetes

October 24, 2017

Adolescents who take antidepressants may have an increased risk for developing type 2 diabetes, according to a new study.

Quick Hits: Invokana and Amputations, Nonprescription Ritalin Side Effects, & a Postmarket Studies Lag

May 18, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

Patients Taking Invokana Have an Increased Risk of Leg and Foot Amputations The FDA reports that the type 2 diabetes medicine Invokana (canagliflozin) causes an increased risk of leg and foot amputations. Two large clinical trials showed that leg and foot amputations occurred about twice as often in patients treated Continue Reading →

Aggressive Diabetes Treatment May Harm Some Patients

June 8, 2016
Aggressive Diabetes Treatment May Harm Some Patients

Many people who have diabetes, particularly seniors, are so aggressively treated for the condition with many drugs that it may be putting them at risk for dangerously low blood sugar levels.

Researchers examined data on more than 31,000 adults with type 2 diabetes. About 20% of those studied were considered Continue Reading →

Quick Hits: FDA Approves New Drug for MS, Diabetes & More

June 2, 2016
Quick Hits: Drug Interactions With Emergency Contraceptives, Liquid Medicine Dosing Errors, & More

Zinbryta (daclizumab), a monthly self-administered injection that aids in the treatment of relapsing forms of multiple sclerosis, has been approved by the FDA. Due to Zinbryta’s serious side effects including liver injury and immune conditions, it is recommended that the drug only be used in patients who have had a Continue Reading →

Quick Hits: Amputation Risk With Diabetes Med, & More

May 19, 2016
Quick Hits: Drug Interactions With Emergency Contraceptives, Liquid Medicine Dosing Errors, & More

People taking the diabetes medication Invokana may be at risk for leg and foot amputations. The FDA is alerting the public about interim safety results from an ongoing clinical trial that found an increase in the amputations, mostly affecting the toes, in patients taking Invokana (canagliflozin). The FDA has not Continue Reading →